DermaRite Recall: How Burkholderia cepacia Contaminated DermaKleen, KleenFoam, DermaSarra & PeriGiene—What You Need to Know

1. Introduction / Hook

Start strong with urgency and clarity:

On August 8, 2025, DermaRite Industries, LLC issued a voluntary nationwide recall of several OTC hygiene products—including DermaKleen, KleenFoam, DermaSarra, and PeriGiene—due to contamination by the antibiotic-resistant bacterium Burkholderia cepacia, which can cause severe and potentially life-threatening infections. U.S. Food and Drug AdministrationPeople.com

2. What’s Being Recalled

Detail the products and their intended uses:

• DermaKleen – antiseptic lotion soap with Vitamin E for handwashing U.S. Food and Drug Administration
• KleenFoam – antimicrobial foam soap with Aloe Vera for hand hygiene U.S. Food and Drug Administration
• DermaSarra – external analgesic lotion for itchy, irritated skin U.S. Food and Drug Administration
• PeriGiene – antiseptic cleanser for perineal hygiene U.S. Food and Drug Administration

Distribution: nationwide across the U.S. and Puerto Rico U.S. Food and Drug Administration

3. The Risk: Why It Matters

Explain the threat in plain but compelling terms:

• The products were contaminated with Burkholderia cepacia complex, a resilient bacterium known to resist multiple antibiotics People.comHouston ChronicleABC News.
• For immunocompromised individuals, use could lead to bloodstream infections and life-threatening sepsis; for healthy users, especially those with minor skin cuts, the risk is localized infections U.S. Food and Drug AdministrationPeople.comHouston Chronicle.
• As of the recall, no adverse events had been reported U.S. Food and Drug AdministrationHouston ChroniclePeople.com.

4. Immediate Actions for Consumers

Provide practical steps readers should follow:

• Stop using any products from the recalled lines immediately.
• Check product labels, lot numbers, and expiration dates (ranging from July 2025 to February 2027) ABC NewsABC7 New York.
• If you experience symptoms—fever, fatigue, redness, or other signs of infection—seek medical attention promptly People.comHouston Chronicle.
• Report adverse reactions to the FDA’s MedWatch program online, by mail, or fax U.S. Food and Drug Administration.

5. Corporate and Regulatory Response

Summarize the official steps and contact points:

• DermaRite sent email notifications to distributors and customers, instructing them to destroy any recalled inventory according to proper procedures U.S. Food and Drug Administration.
• Contact for inquiries: Mary Goldberg at 973-569-9000 ext. 104 (Mon–Fri, EST) or voluntary.action@dermarite.com U.S. Food and Drug Administration.
• The FDA published this recall with the company’s cooperation and continues to monitor the situation U.S. Food and Drug Administration.